Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)

NCT05135403 is registered in ClinicalTrials.gov with Kestra Medical Technologies, Inc. as lead sponsor.

NCT NCT05135403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Lead sponsor
Kestra Medical Technologies, Inc.
Phase
Observational
Overall status
Recruiting
Start date
November 20, 2021
Completion date
October 1, 2025
Enrollment
5,179 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sudden cardiac arrest